Are we confident treating pT1a G1 lymphovascular space invasion-negative patients (with myometrial invasion) with chemoradiotherapy on the basis of p53abn?

Int J Gynecol Cancer. 2021 Jun;31(6):946. doi: 10.1136/ijgc-2021-002630. Epub 2021 Apr 28.

Authors

Anna Merlotti¹, Elvio Russi², Vitaliana De Sanctis³

Affiliations

¹ Department of Radiation Oncology, S Croce and Carle Cuneo Hospital Districts, Cuneo, Italy [email protected].
² Department of Radiation Oncology, S Croce and Carle Cuneo Hospital Districts, Cuneo, Italy.
³ Department of Medicine and Surgery and Translational Medicine, Radiation Oncology, S Andrea Hospital, Sapienza University of Rome, Rome, Italy.

PMID: 33911003
DOI: 10.1136/ijgc-2021-002630

No abstract available

Keywords: endometrial neoplasms.

Publication types

Letter
Comment

MeSH terms

Chemoradiotherapy
Endometrial Neoplasms* / drug therapy
Female
Humans
Myometrium